![Joel Bennett Braunstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joel Bennett Braunstein
Fondatore presso LifeTech Research, Inc.
Posizioni attive di Joel Bennett Braunstein
Società | Posizione | Inizio | Fine |
---|---|---|---|
LifeTech Research, Inc.
![]() LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling. | Analyst-Equity | 01/01/2003 | - |
Amministratore Delegato | 01/01/2003 | - | |
Fondatore | 01/01/2003 | - | |
Centegen, Inc.
![]() Centegen, Inc. BiotechnologyHealth Technology Centegen, Inc. develops novel therapeutics to fight serious drug resistant bacterial infections. The company was founded by Dr. Joel B. Braunstein and is headquartered in Pikesville, MD. | Amministratore Delegato | - | - |
Presidente | - | - | |
LifeTech Development Partners LP
![]() LifeTech Development Partners LP Investment ManagersFinance LifeTech Development Partners LP (LifeTech Development) is a venture capital subsidiary of LifeTech Research, Inc. founded in 2008 by Joel Braunstein. The firm is headquartered in Baltimore, Maryland. | Fondatore | 01/01/2008 | - |
Investitore di Private Equity | 01/01/2008 | - | |
C2N Diagnostics LLC
![]() C2N Diagnostics LLC BiotechnologyHealth Technology C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation. | Direttore/Membro del Consiglio | 01/01/2007 | - |
Amministratore Delegato | 01/01/2007 | - | |
Fondatore | 01/01/2007 | - | |
Presidente | 01/01/2007 | - |
Storia della carriera di Joel Bennett Braunstein
Precedenti posizioni note di Joel Bennett Braunstein
Società | Posizione | Inizio | Fine |
---|---|---|---|
Tivorsan Pharmaceuticals, Inc.
![]() Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI. | Direttore/Membro del Consiglio | - | 01/12/2019 |
Fondatore | - | 01/12/2019 | |
NexGen Medical Systems, Inc.
![]() NexGen Medical Systems, Inc. Medical SpecialtiesHealth Technology NexGen Medical Systems, Inc. develops medical devices that enhance the safety and effectiveness of interventional procedures in patients with debilitating neurological and cardiovascular diseases. The firm focuses on commercializing an integrated medical device product line for removal of blood clots from head, neck, and peripheral vessels. The company was founded by Richard E. Latchaw, John Kucharczyk and George T. Gillies and is headquartered in Wayzata, MN. | Presidente | - | - |
Correx, Inc.
![]() Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Direttore/Membro del Consiglio | 23/02/2011 | - |
NexGen Medical Systems, Inc.
![]() NexGen Medical Systems, Inc. Medical SpecialtiesHealth Technology NexGen Medical Systems, Inc. develops medical devices that enhance the safety and effectiveness of interventional procedures in patients with debilitating neurological and cardiovascular diseases. The firm focuses on commercializing an integrated medical device product line for removal of blood clots from head, neck, and peripheral vessels. The company was founded by Richard E. Latchaw, John Kucharczyk and George T. Gillies and is headquartered in Wayzata, MN. | Direttore/Membro del Consiglio | 22/07/2010 | - |
Formazione di Joel Bennett Braunstein
Northwestern University | Doctorate Degree |
The Johns Hopkins University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Posizioni
Director/Board Member | 4 |
Founder | 4 |
Chief Executive Officer | 3 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 7 |
---|---|
Centegen, Inc.
![]() Centegen, Inc. BiotechnologyHealth Technology Centegen, Inc. develops novel therapeutics to fight serious drug resistant bacterial infections. The company was founded by Dr. Joel B. Braunstein and is headquartered in Pikesville, MD. | Health Technology |
NexGen Medical Systems, Inc.
![]() NexGen Medical Systems, Inc. Medical SpecialtiesHealth Technology NexGen Medical Systems, Inc. develops medical devices that enhance the safety and effectiveness of interventional procedures in patients with debilitating neurological and cardiovascular diseases. The firm focuses on commercializing an integrated medical device product line for removal of blood clots from head, neck, and peripheral vessels. The company was founded by Richard E. Latchaw, John Kucharczyk and George T. Gillies and is headquartered in Wayzata, MN. | Health Technology |
Correx, Inc.
![]() Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Health Technology |
LifeTech Research, Inc.
![]() LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling. | Finance |
LifeTech Development Partners LP
![]() LifeTech Development Partners LP Investment ManagersFinance LifeTech Development Partners LP (LifeTech Development) is a venture capital subsidiary of LifeTech Research, Inc. founded in 2008 by Joel Braunstein. The firm is headquartered in Baltimore, Maryland. | Finance |
C2N Diagnostics LLC
![]() C2N Diagnostics LLC BiotechnologyHealth Technology C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation. | Health Technology |
Tivorsan Pharmaceuticals, Inc.
![]() Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI. | Health Technology |